XORTX Therapeutics (XRTX) Non-cash Items (2020 - 2026)
XORTX Therapeutics (XRTX) posted Non-cash Items of -$501362.0 for Q1 2026, up 28.57% on a QoQ basis from -$701857.0 in Q4 2025, and up 22.12% year-over-year from -$410561.7 in Q1 2025.
XORTX Therapeutics (XRTX) Non-cash Items (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Non-cash Items history runs 7 years deep, the most recent figure standing at -$501362.0 for Q1 2026.
- Quarterly Non-cash Items rose 22.12% year-over-year to -$501362.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 297.27% YoY) and the FY2025 annual result came in at -$2.8 million, down 175.26% from the prior year.
- Non-cash Items was -$501362.0 for Q1 2026 at XORTX Therapeutics, up from -$701857.0 in the prior quarter.
- Across five years, Non-cash Items topped out at $11.9 million in Q4 2023 and bottomed at -$3.8 million in Q4 2022.
- A 5-year average of -$126129.9 and a median of -$793519.0 in 2025 frame the typical range for Non-cash Items.
- Annual changes were most pronounced in 2022 — Non-cash Items plunged 9976.87% — and 2023, when it jumped 412.41%.
- XORTX Therapeutics' Non-cash Items stood at -$3.8 million in 2022, then soared by 412.41% to $11.9 million in 2023, then slumped by 45.48% to $6.5 million in 2024, then slumped by 110.85% to -$701857.0 in 2025, then advanced by 28.57% to -$501362.0 in 2026.
- Business Quant data shows XRTX's Non-cash Items at -$501362.0 in Q1 2026, -$701857.0 in Q4 2025, and -$629617.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -501,362.00 |
| Mar 31, 2026 | -501,362.00 |
| Dec 31, 2025 | -701,857.00 |
| Dec 31, 2025 | -701,857.00 |
| Sep 30, 2025 | -629,617.00 |
| Sep 30, 2025 | -629,617.00 |
| Jun 30, 2025 | -793,519.00 |
| Jun 30, 2025 | -793,519.00 |
| Mar 31, 2025 | -643,730.00 |
| Mar 31, 2025 | -643,730.00 |
| Dec 31, 2024 | 6.47 Mn |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | -751,851.00 |
| Sep 30, 2024 | -751,851.00 |
| Jun 30, 2024 | -3.74 Mn |
| Jun 30, 2024 | -3.74 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 11.87 Mn |
| Dec 31, 2023 | 11.87 Mn |